Royalty Pharma plc — Director's Dealing 2026

Jan 6, 2026

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2026-01-01

Reporting Person: McGivern Arthur Richard (EVP, Investments & GC)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class E Ordinary Shares	$0		Class A Ordinary Shares (706393)		Indirect
Restricted Share Units (RSU)	$0		Class A Ordinary Shares (24441)		Direct

Footnotes

F1: Each Class E ordinary share ("Class E Share") of Royalty Pharma Holdings Ltd ("RPH") will vest in installments over a 8-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.

F2: The RSUs vest quarterly as to 1/16th of the total RSUs underlying the original grant on October 11, 2022, subject to continued service through each vesting date.